https://kaijiwire.jp/companies/7120001077374 小野薬品工業株式会社の官報公告・EDINET提出・プレスリリース等の履歴(開示ワイヤー) ja https://www.pmda.go.jp/review-services/drug-reviews/review-information/p-drugs/0040.html?row=4f0a4d72b132 https://kaijiwire.jp/companies/7120001077374#event-01a0ee31-af08-780b-bc69-9082ca8fc454 Wed, 16 Sep 2026 00:00:00 +0900 成分名: セノバメート / 効能・効果: てんかん患者の部分発作(二次性全般化発作を含む) https://prtimes.jp/main/html/rd/p/000000038.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a057d1-123f-78bd-a971-a1ef6e4dd7ae Tue, 25 Aug 2026 09:30:02 +0900 https://prtimes.jp/main/html/rd/p/000000041.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a00f2a-7c2c-7421-ba46-c4423ff153c4 Mon, 17 Aug 2026 15:00:01 +0900 https://kaijiwire.jp/edinet/019fd668-8064-761c-a61f-e85100348265 https://kaijiwire.jp/companies/7120001077374#event-019fd668-8064-761c-a61f-e85100348265 Wed, 5 Aug 2026 16:16:00 +0900 変更報告書(特例対象株券等) https://kaijiwire.jp/companies/7120001077374 https://kaijiwire.jp/companies/7120001077374#event-01a07183-bd14-7c70-945a-374f6846cc88 Fri, 31 Jul 2026 12:00:00 +0900 2027年3月期第1四半期決算短信〔IFRS〕(連結) https://prtimes.jp/main/html/rd/p/000000040.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a057d1-1526-7644-b2f1-e15ddee243ec Thu, 30 Jul 2026 15:13:01 +0900 https://prtimes.jp/main/html/rd/p/000000039.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a057d1-17cc-74fd-b8d3-d401dc9baafa Wed, 29 Jul 2026 16:13:12 +0900 https://kaijiwire.jp/edinet/019f4636-6f61-74e9-a7b3-f28de74e3392 https://kaijiwire.jp/companies/7120001077374#event-019f4636-6f61-74e9-a7b3-f28de74e3392 Wed, 8 Jul 2026 15:00:00 +0900 訂正有価証券報告書-第78期(2025/04/01-2026/03/31) https://kaijiwire.jp/edinet/019ee45d-9e6f-7d0e-ac6d-213892e610ad https://kaijiwire.jp/companies/7120001077374#event-019ee45d-9e6f-7d0e-ac6d-213892e610ad Fri, 19 Jun 2026 09:00:00 +0900 臨時報告書 https://kaijiwire.jp/edinet/019edf37-4024-722e-981a-623535df9cef https://kaijiwire.jp/companies/7120001077374#event-019edf37-4024-722e-981a-623535df9cef Thu, 18 Jun 2026 16:00:00 +0900 臨時報告書 https://kaijiwire.jp/edinet/019ecfc4-2b88-7935-94d3-a9fb78bc747a https://kaijiwire.jp/companies/7120001077374#event-019ecfc4-2b88-7935-94d3-a9fb78bc747a Mon, 15 Jun 2026 09:00:00 +0900 有価証券報告書-第78期(2025/04/01-2026/03/31) https://prtimes.jp/main/html/rd/p/000000033.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a057d1-1a5a-7f5d-b0b9-68f21c6d3677 Thu, 11 Jun 2026 16:00:02 +0900 https://kaijiwire.jp/companies/7120001077374 https://kaijiwire.jp/companies/7120001077374#event-01a07181-8ad0-7c5c-b703-8f4c320195c8 Fri, 8 May 2026 12:00:00 +0900 2026年3月期決算短信〔IFRS〕(連結) https://prtimes.jp/main/html/rd/p/000000035.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a057d1-1cfb-7250-a966-cb2952246fbc Mon, 9 Mar 2026 17:00:01 +0900 https://kaijiwire.jp/edinet/019d2681-99e7-7f7c-a148-8972e9da521f https://kaijiwire.jp/companies/7120001077374#event-019d2681-99e7-7f7c-a148-8972e9da521f Thu, 5 Mar 2026 11:30:00 +0900 臨時報告書 https://kaijiwire.jp/edinet/019d2680-13b4-7567-bb89-b77d856213cf https://kaijiwire.jp/companies/7120001077374#event-019d2680-13b4-7567-bb89-b77d856213cf Tue, 3 Feb 2026 16:36:00 +0900 変更報告書(特例対象株券等) https://prtimes.jp/main/html/rd/p/000000034.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a057d1-1fa2-7ab4-8b0f-1bf5c239a6fc Tue, 3 Feb 2026 13:00:02 +0900 https://prtimes.jp/main/html/rd/p/000000032.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a057d1-223c-7dd0-a153-a9d2b977df9c Thu, 11 Dec 2025 13:00:02 +0900 https://www.pmda.go.jp/review-services/drug-reviews/review-information/p-drugs/0039.html?row=26ce32221ad1 https://kaijiwire.jp/companies/7120001077374#event-01a0ee31-ad2e-78ac-8bac-6c7249332b72 Thu, 20 Nov 2025 00:00:00 +0900 成分名: エンコラフェニブ / 効能・効果: BRAF遺伝子変異を有する治癒切除不能な進行・再発の結腸・直腸癌 / 希少疾病用医薬品 https://prtimes.jp/main/html/rd/p/000000031.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a057d1-24c8-78fb-a1b9-6ac8bc09863f Wed, 19 Nov 2025 13:00:02 +0900 https://kaijiwire.jp/edinet/019d267b-4bb4-7a61-86bf-38eaba36e25c https://kaijiwire.jp/companies/7120001077374#event-019d267b-4bb4-7a61-86bf-38eaba36e25c Thu, 6 Nov 2025 09:00:00 +0900 半期報告書-第78期(2025/04/01-2026/03/31) https://kaijiwire.jp/edinet/019d267b-3eb2-7551-bd35-5ee3681b1cb5 https://kaijiwire.jp/companies/7120001077374#event-019d267b-3eb2-7551-bd35-5ee3681b1cb5 Wed, 5 Nov 2025 16:08:00 +0900 大量保有報告書(特例対象株券等) https://prtimes.jp/main/html/rd/p/000000030.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a057d1-2752-720b-a5d0-d454bb535a3b Mon, 29 Sep 2025 08:30:02 +0900 https://kaijiwire.jp/edinet/019d2678-c916-79fb-af08-bd1177381782 https://kaijiwire.jp/companies/7120001077374#event-019d2678-c916-79fb-af08-bd1177381782 Fri, 19 Sep 2025 10:31:00 +0900 変更報告書(特例対象株券等) https://kaijiwire.jp/edinet/019d2677-f272-765d-aeda-bc734fef7fe7 https://kaijiwire.jp/companies/7120001077374#event-019d2677-f272-765d-aeda-bc734fef7fe7 Wed, 3 Sep 2025 16:00:00 +0900 変更報告書(特例対象株券等) https://www.pmda.go.jp/review-services/drug-reviews/review-information/p-drugs/0039.html?row=03580f607a96 https://kaijiwire.jp/companies/7120001077374#event-01a0ee31-acec-7501-b8af-399cf54e902c Mon, 25 Aug 2025 00:00:00 +0900 成分名: ニボルマブ(遺伝子組換え) / 効能・効果: 治癒切除不能な進行・再発の高頻度マイクロサテライト不安定性(MSI-High)を有する結腸・直腸癌 / 希少疾病用医薬品 https://prtimes.jp/main/html/rd/p/000000029.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a05dd2-4626-7011-9354-3c873774b04a Thu, 7 Aug 2025 10:35:46 +0900 https://kaijiwire.jp/edinet/019d2676-54ac-7d68-b37f-2ccb93652e99 https://kaijiwire.jp/companies/7120001077374#event-019d2676-54ac-7d68-b37f-2ccb93652e99 Mon, 4 Aug 2025 09:00:00 +0900 臨時報告書 https://prtimes.jp/main/html/rd/p/000000028.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a05dd2-48ae-75fc-965e-71b9e4e463ba Tue, 29 Jul 2025 14:00:02 +0900 https://kaijiwire.jp/edinet/019d2674-7cc2-7697-827c-cf7e9059f9ed https://kaijiwire.jp/companies/7120001077374#event-019d2674-7cc2-7697-827c-cf7e9059f9ed Tue, 1 Jul 2025 16:00:00 +0900 訂正有価証券報告書-第77期(2024/04/01-2025/03/31) https://www.pmda.go.jp/review-services/drug-reviews/review-information/p-drugs/0039.html?row=c39411721461 https://kaijiwire.jp/companies/7120001077374#event-01a0ee31-acde-7b3a-bc8e-9503154c7382 Tue, 24 Jun 2025 00:00:00 +0900 成分名: ニボルマブ(遺伝子組換え) / 効能・効果: 切除不能な肝細胞癌 https://kaijiwire.jp/edinet/019d2673-994e-7828-8230-62ac1f4c6d0a https://kaijiwire.jp/companies/7120001077374#event-019d2673-994e-7828-8230-62ac1f4c6d0a Fri, 20 Jun 2025 09:00:00 +0900 臨時報告書 https://kaijiwire.jp/edinet/019d2673-8325-7c1f-a382-434080930799 https://kaijiwire.jp/companies/7120001077374#event-019d2673-8325-7c1f-a382-434080930799 Thu, 19 Jun 2025 16:06:00 +0900 臨時報告書 https://kaijiwire.jp/edinet/019d2673-8329-79f8-99d0-f9a93ddcfb74 https://kaijiwire.jp/companies/7120001077374#event-019d2673-8329-79f8-99d0-f9a93ddcfb74 Thu, 19 Jun 2025 16:05:00 +0900 臨時報告書 https://kaijiwire.jp/edinet/019d2673-8346-732c-b960-fa371a0c5830 https://kaijiwire.jp/companies/7120001077374#event-019d2673-8346-732c-b960-fa371a0c5830 Thu, 19 Jun 2025 16:00:00 +0900 有価証券報告書-第77期(2024/04/01-2025/03/31) https://prtimes.jp/main/html/rd/p/000000027.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a05dd2-4b41-77b5-b4c8-0c8d23cdfce5 Wed, 18 Jun 2025 13:51:12 +0900 https://prtimes.jp/main/html/rd/p/000000026.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a05dd2-4dfa-7bbe-b9c8-85a1398038dc Sat, 19 Apr 2025 10:30:01 +0900 https://prtimes.jp/main/html/rd/p/000000025.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a05dd2-5091-7570-9d39-fbc8ed4c178f Mon, 3 Feb 2025 15:00:02 +0900 https://prtimes.jp/main/html/rd/p/000000022.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a05dd2-5338-7f15-8f95-46bfb049163a Tue, 24 Dec 2024 11:00:05 +0900 https://prtimes.jp/main/html/rd/p/000000023.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a05dd2-55dc-75e5-bcf9-0940bc6d4416 Wed, 18 Dec 2024 11:30:04 +0900 https://prtimes.jp/main/html/rd/p/000000021.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a05dd2-5884-7cee-893b-e9eda25da924 Wed, 16 Oct 2024 15:00:02 +0900 https://prtimes.jp/main/html/rd/p/000000018.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a05dd2-5b12-70e3-98e3-c785491a716d Tue, 1 Oct 2024 13:00:01 +0900 https://prtimes.jp/main/html/rd/p/000000016.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a05dd2-5da7-7de6-b8b8-f195f2f6f096 Tue, 20 Aug 2024 13:00:01 +0900 https://prtimes.jp/main/html/rd/p/000000015.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a05dd2-6038-7e88-b176-e8cec82c5d66 Wed, 24 Jul 2024 16:30:01 +0900 https://prtimes.jp/main/html/rd/p/000000013.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a05dd2-62c7-79df-b07a-ec7c2e475a1c Wed, 12 Jun 2024 11:20:19 +0900 https://prtimes.jp/main/html/rd/p/000000011.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a05dd2-654c-758e-b8f4-fc4aa9172859 Wed, 10 Apr 2024 11:06:03 +0900 https://prtimes.jp/main/html/rd/p/000000009.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a05dd2-67f1-7d26-86ab-8a70dd7d096e Wed, 27 Mar 2024 14:00:02 +0900 https://prtimes.jp/main/html/rd/p/000000007.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a05dd2-6d1d-79d2-804a-e02359176421 Mon, 11 Mar 2024 17:00:03 +0900 https://prtimes.jp/main/html/rd/p/000000008.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a05dd2-6a85-7052-bc68-0ede007b7e36 Mon, 11 Mar 2024 11:49:50 +0900 https://prtimes.jp/main/html/rd/p/000000006.000131503.html https://kaijiwire.jp/companies/7120001077374#event-01a05dd2-708c-7dcd-982d-dee3342d1c58 Wed, 7 Feb 2024 11:36:10 +0900